Why Did Ken Griffin Buy Sweetgreen Stock?
In Q1, Ken Griffin’s Citadel Advisors purchased nearly 1.3 million…
Buy
61
BMRN Quote, Financials, Valuation and Earnings
Last price:
$57.15
Seasonality move
:
2.32%
Day range:
$57.02 - $57.99
52-week range:
$52.93 - $94.85
Dividend yield:
0%
P/E ratio:
21.25x
P/S ratio:
3.83x
P/B ratio:
1.89x
Volume:
1.8M
Avg. volume:
2.2M
1-year change:
-31.85%
Market cap:
$11B
Revenue:
$2.9B
EPS (TTM):
$2.69
BMRN Analysts' Consensus Rating
The 22 analysts providing 12-month price projections for Biomarin Pharmaceutical shares anticipate an average target of $95.91, ranging from a low estimate of $65.00 to a high estimate of $122.00. This average target implies a growth of 67.79% compared to the current stock price of $57.16.
Consensus Price Target
$95.91
Highest Price Target
$122.00
Lowest Price Target
$65.00
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 14 | 16 | 16 |
| Hold | 7 | 6 | 6 |
| Sell | 0 | 0 | 0 |
| Consensus | Buy | Buy | Buy |
BMRN Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will Planet Labs’ Stock Go Next?
On 4 June 2025 Planet reported Q1 FY 2026 revenue of $66.3 million, up 10% year over…
Where Will VICI Properties Be in 5 Years?
VICI Properties (NYSE:VICI) is a real estate investment trust focused…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 40x
Buy
61
Is NVDA Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 49x
Sell
39
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Buy
73
OKLO alert for Jun 12
Oklo [OKLO] is up 29.48% over the past day.
Buy
87
SMR alert for Jun 12
NuScale Power [SMR] is up 20.55% over the past day.
Buy
53
PLAY alert for Jun 12
Dave & Buster's Entertainment [PLAY] is up 17.78% over the past day.
